Literature DB >> 33541402

Barriers impacting the POINT pragmatic trial: the unavoidable overlap between research and intervention procedures in "real-world" research.

Allyson L Dir1, Dennis P Watson2, Matthew Zhiss3, Lisa Taylor4, Bethany C Bray4, Alan McGuire5,6.   

Abstract

BACKGROUND: This manuscript provides a research update to the ongoing pragmatic trial of Project POINT (Planned Outreach, Intervention, Naloxone, and Treatment), an emergency department-based peer recovery coaching intervention for linking patients with opioid use disorder to evidence-based treatment. The research team has encountered a number of challenges related to the "real-world" study setting since the trial began. Using an implementation science lens, we sought to identify and describe barriers impacting both the intervention and research protocols of the POINT study, which are often intertwined in pragmatic trials due to the focus on external validity.
METHOD: Qualitative data were collected from 3 peer recovery coaches, 2 peer recovery coach supervisors, and 3 members of the research team. Questions and deductive qualitative analysis were guided by the Consolidated Framework for Implementation Research (CFIR).
RESULTS: Nine unique barriers were noted, with 5 of these barriers impacting intervention and research protocol implementation simultaneously. These simultaneous barriers were timing of intervention delivery, ineffective communication with emergency department staff, lack of privacy in the emergency department, the fast-paced emergency department setting, and patient's limited resources. Together, these barriers represent the intervention characteristics, inner setting, and outer setting domains of the CFIR.
CONCLUSION: Results highlight the utility of employing an implementation science framework to assess implementation issues in pragmatic trials and how this approach might be used as a quality assurance mechanism given the considerable overlap that exists between research and intervention protocols in real-world trial settings. Previously undocumented changes to the trial design that have been made as a result of the identified barriers are discussed.

Entities:  

Keywords:  Consolidated Framework for Implementation Research; Emergency department; External validity; Implementation; Medication for opioid use disorder; Opioid use disorder; Overdose; Pragmatic trial

Mesh:

Substances:

Year:  2021        PMID: 33541402      PMCID: PMC7859893          DOI: 10.1186/s13063-021-05065-3

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.279


  30 in total

1.  Pragmatic Clinical Trials: Implementation Opportunity, or Just Another Fad?

Authors:  Anthony Delitto
Journal:  Phys Ther       Date:  2016-02

Review 2.  Developing and selecting interventions for translating knowledge to action.

Authors:  Michel Wensing; Marije Bosch; Richard Grol
Journal:  CMAJ       Date:  2009-12-21       Impact factor: 8.262

Review 3.  Peer recovery support for individuals with substance use disorders: assessing the evidence.

Authors:  Sharon Reif; Lisa Braude; D Russell Lyman; Richard H Dougherty; Allen S Daniels; Sushmita Shoma Ghose; Onaje Salim; Miriam E Delphin-Rittmon
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

4.  Introduction to the special issue on innovative interventions and approaches to expand medication assisted treatment: Seizing research opportunities made available by the opioid STR program.

Authors:  Dennis P Watson; Barbara Andraka-Christou; Thomas Clarke; Julie Wiegandt
Journal:  J Subst Abuse Treat       Date:  2019-10-23

5.  A Longitudinal Mixed Method Approach for Assessing Implementation Context and Process Factors: Comparison of Three Sites from a Housing First Implementation Strategy Pilot.

Authors:  Dennis P Watson; Nyssa Snow-Hill; Lisa Saldana; Angela L Walden; Monte Staton; Angela Kong; Geri Donenberg
Journal:  Implement Res Pract       Date:  2020-12-01

6.  Methods and metrics challenges of delivery-system research.

Authors:  Jeffrey A Alexander; Larry R Hearld
Journal:  Implement Sci       Date:  2012-03-12       Impact factor: 7.327

7.  Lived Experience in New Models of Care for Substance Use Disorder: A Systematic Review of Peer Recovery Support Services and Recovery Coaching.

Authors:  David Eddie; Lauren Hoffman; Corrie Vilsaint; Alexandra Abry; Brandon Bergman; Bettina Hoeppner; Charles Weinstein; John F Kelly
Journal:  Front Psychol       Date:  2019-06-13

8.  The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.

Authors:  Stuart G Nicholls; Kelly Carroll; Merrick Zwarenstein; Jamie C Brehaut; Charles Weijer; Spencer P Hey; Cory E Goldstein; Ian D Graham; Jeremy M Grimshaw; Joanne E McKenzie; Dean A Fergusson; Monica Taljaard
Journal:  Trials       Date:  2019-12-23       Impact factor: 2.279

9.  Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.

Authors:  Marshall Godwin; Lucia Ruhland; Ian Casson; Susan MacDonald; Dianne Delva; Richard Birtwhistle; Miu Lam; Rachelle Seguin
Journal:  BMC Med Res Methodol       Date:  2003-12-22       Impact factor: 4.615

Review 10.  Defining the external implementation context: an integrative systematic literature review.

Authors:  Dennis P Watson; Erin L Adams; Sarah Shue; Heather Coates; Alan McGuire; Jeremy Chesher; Joanna Jackson; Ogbonnaya I Omenka
Journal:  BMC Health Serv Res       Date:  2018-03-27       Impact factor: 2.655

View more
  2 in total

1.  Implementation Challenges and Recommendations for Employing Peer Support Workers in Emergency Departments to Support Patients Presenting after an Opioid-Related Overdose.

Authors:  Annette S Crisanti; Jennifer Earheart; Megan Deissinger; Kathryn Lowerre; Julie G Salvador
Journal:  Int J Environ Res Public Health       Date:  2022-04-26       Impact factor: 4.614

2.  Lessons Learned from Implementing the SHIELD Intervention: A Peer Education Intervention for People Who Use Drugs.

Authors:  Melissa Davey-Rothwellh; Jill Owczarzak; Karina Collins; M Margaret Dolcini; Karin Tobin; Frances Mitchell; Abenea Jones; Carl Latkin
Journal:  AIDS Behav       Date:  2021-04-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.